Is There A Big Pharma Fox In The Anti-Addiction Hen House? – By David Marcus – January 29, 2018
The American Society of Addiction Medicine (ASAM) was founded in 1954 to study and improve the use of addictive substances in health care. In the half-century since, it has become a leading voice in the medical community with important reach into legislative and regulatory initiatives to abate the abuse of addictive drugs.
Although it casts itself as an impartial organization, there are reasons to question whether the pharmaceutical industry has undue influence that may affect the organization’s advice. Continue reading
Richard Sackler, member of family behind OxyContin, was granted patent for addiction treatment – By Andrew Joseph @DrewQJoseph – Sept 2018
Again, truth proves to be stranger than fiction. Apparently, there’s money to be made from both leading into and leading out of addiction, so I suppose it’s natural that a pharmaceutical company would follow the money.
A member of the family that owns Purdue Pharma — which is being sued by more than 1,000 jurisdictions for its alleged role in seeding the opioid crisis with its pain medication OxyContin — has been awarded a patent for a treatment for opioid use disorder.
Critics told the FT that they were disturbed that the patent could enable Sackler to benefit financially from the addiction crisis that his family’s company is accused of fueling. Continue reading
The other side of Suboxone – KevinMD – July 2018 – by Dennis Wichern
There are no good or bad opioids, there are only good or bad ways to use them.
A lot has been written about Suboxone, the buprenorphine treatment drug.
For many, Suboxone acts as an effective medication to treat opioid addiction.
For others, it’s a highly-valued street drug that is commonly diverted and misused. To understand and acknowledge the darker side of Suboxone we have to look back at its history over the past 16 years. Continue reading
Opioid bills could net millions for companies – By Adam Cancryn – June 2018
The House is touting passage of dozens of bills that could help combat the national opioid crisis — but a small handful of companies that have spent millions lobbying Congress could reap a windfall if any of the bills become law.
In a two-week legislative blitz, the House cleared several narrowly tailored measures that would spur sales for companies that have ramped up their influence game in Washington, according to a review of the more than five dozen bills up for votes.
Those poised to benefit include: Continue reading
What the media gets wrong about opioids – By Maia Szalavitz – Aug 2018
After Jillian Bauer-Reese created an online collection of opioid recovery stories, she began to get calls for help from reporters. But she was dismayed by the narrowness of the requests, which sought only one type of interviewee.
“They were looking for people who had started on a prescription from a doctor or a dentist,” says Bauer-Reese, an assistant professor of journalism at Temple University in Philadelphia. “They had essentially identified a story that they wanted to tell and were looking for a character who could tell that story.”
Just like the latest research on opioids, the result is assumed before they even start. I don’t understand how this negligence became standard practice. Continue reading
Moral Crusades and Moral Panics as a Means of Social Control in the Medical Profession – March 2016
Though the author is writing about the witch hunt and punishment of doctors suspected of drug abuse, this article is equally pertinent to pain patients who are always suspected (if not downright accused) of drug abuse.
Sociologist Stanley Cohen used the term ”moral panic” to characterize the amplification of deviance by the media, the public, and agents of social control.
Labeled as being outside the central core values of consensual society, the deviants in the designated group are perceived as posing a threat to both the values of society and society itself. Belief in the seriousness of the situation justifies intolerance and unfair treatment of the accused. The evidentiary standard is lowered. Continue reading
Overdose and Other Drug and Addiction Myths – Psychology Today – by Stanton Peele Ph.D. – Jan 2018
- Drug Overdose
Tom Petty died from, according to the New York Times headline (link is external), an “Accidental Drug Overdose.”
Here’s the coroner’s list of the drugs found in Petty’s system:
- acetyl fentanyl and
- despropionyl fentanyl.
Pain Tolerance in Buprenorphine Maintenance Treatment – by Brandon May – April 13, 2018
Here’s an article showing the potential danger of this treatment, which results from buprenorphine binding more tightly to opioid receptors. Therefore it blocks more effective opioids while not relieving pain as well itself.
The actual study detailed in this article has a more bluntly honest title: Buprenorphine maintenance subjects are hyperalgesic and have no antinociceptive [pain relief] response to a very high morphine dose .
And from Wikipedia: “People on high-dose buprenorphine therapy may be unaffected by even large doses of opioids for episodes of acute pain. It is also difficult to achieve acute opioid analgesia in persons using buprenorphine for opioid replacement therapy.” Continue reading
Questions Raised About Study Of Device To Ease Opioid Withdrawal– May 2, 2018 – NPR – by Jake Harper
The financial sharks are attracted to the “opioid crisis” (we are merely chum in the waters), seeing in it an opportunity to make huge profits.
Becuase there is no real science involved in determining who needs addiction-treatment, they can sell anything that seems to be even a little bit effective.
To the untrained, the evidence looks promising for a new medical device to ease opioid withdrawal. A small study shows that people feel better when the device, an electronic nerve stimulator called the Bridge, is placed behind their ear. Continue reading
Fraud’s Newest Hot Spot: The Opioid Epidemic And The Corresponding Rise Of Unethical Addiction Treatment Providers – April 2018 – by Anuradha Rao-Patel, Michael Adelberg, Samantha Arsenault, Andrew Kessler
For decades, bad actors have followed the money through a string of sophisticated scams—power wheelchairs, home health, ambulance and medical transport, and counterfeit medicines.
SUD treatment was a $9 billion per year industry in 1986 and is now a $35 billion industry that is expected to reach $42 billion in 2020.
Now, the burgeoning opioid crisis is a hot spot for health care fraud. Continue reading